24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Medical Disorders
Resources
Basic InformationLookupsLatest News
Another Study Finds COVID Usually Mild in KidsBlacks, Hispanics Account for More Than Half of COVID Deaths: StudyCollege Kid Coming Home for Thanksgiving? Here's How to Keep Your Family SafeParents' Age Key to Whether Kids Get Vaccinated Against COVID, Study FindsVegan Diets Tied to Higher Bone Fracture RiskThird COVID Vaccine Shows Effectiveness; FDA Approves New TreatmentWhich Kids With COVID Will Get Very Sick?Add Kids to COVID Vaccine Trials, Pediatricians' Group SaysLosing Your Hair Because of Pandemic Stress?How Hospitals Can Cut Patients' FallsMany Young Americans Lonely, Depressed During Pandemic: SurveyWHO Says No to Remdesivir as COVID-19 TreatmentBirx Says U.S. COVID Cases Are Skyrocketing as Holidays ApproachA 'Stunning' Alternative Rx for Arthritic Joints?Are Statin Side Effects 'All in Your Head'?Stay Home This Holiday, CDC and Medical Groups UrgeDirty Air Endangers Homeless People: StudyU.S. Coronavirus Deaths Top a Quarter MillionOxford COVID Vaccine Safe, Effective, Especially in Older AdultsAre High-Dose Blood Thinners Needed for Severe COVID-19?Childhood Lead Exposure Tied to Brain Changes in Middle AgeWith Cold Weather Forcing Patrons Inside, How Safe Are Restaurants?AHA News: Fauci Offers a COVID-19 Lesson and Looks to the Future'A Struggle:' Physical, Mental Ills Can Linger Months After COVID RecoveryExoskeleton Helps Paralyzed People Walk AgainAre You Feeling 'Pandemic Fatigue'?Chinese COVID Vaccine Appears Safe, EffectiveFDA Approves First Rapid COVID Test for Home UseCould Night Shifts Raise Asthma Risk?AHA News: Black, Hispanic People Hospitalized for COVID-19 at Disproportionately High RatesAHA News: COVID-19 Patients of All Ages With Obesity Face Higher Risk of Complications, DeathOverweight With Arthritic Knees? You Might Want to Avoid TennisAnswers to Your Questions About Face MasksHow to Be a Living Liver DonorCoronavirus Immunity Might Last at Least 6 MonthsCalifornia, Iowa Toughen Restrictions as COVID Cases ClimbAllergies Won't Up Your Odds for Severe COVIDCombo 'Polypill' May Cut Heart Attack, Stroke Risk Up to 40%Restful Sleep Could Help Ward Off Heart FailureMany Americans Plan to Party Indoors, Regardless of Risk: SurveyDeadly New Ebola-Like Disease Emerges in BoliviaModerna Vaccine Shows 94.5% Effectiveness Against COVIDGlobal Warming Has Ticks Jumping From Dogs to HumansMore Evidence That Vaping Ups Lung Disease RiskAHA News: Heart Risk Factors Vary Greatly Among Asian ImmigrantsWrongly Prescribing Antibiotics Sets Dangerous PatternLarge Study Finds Blacks, Asians More Vulnerable to COVIDPre-Op 'Brain Games' Might Prevent Post-Op DeliriumEczema More Common Among Black, Hispanic KidsTelemedicine Is Keeping Kids' Asthma Care on Track: Study
Questions and AnswersLinks
Related Topics

Diabetes

What You Need to Know About the Search for a COVID Vaccine

HealthDay News
by Steven Reinberg
Updated: Oct 30th 2020

new article illustration

FRIDAY, Oct. 30, 2020 (HealthDay News) -- Forty-five potential vaccines for COVID-19 are being tested in human trials and many more are being tested in animals.

Researchers are using several approaches to trigger an immune response against SARS-CoV-2, the virus that causes COVID-19. The most common types of vaccines contain a virus that has been engineered with coronavirus genes to provoke an immune response, according to Dr. Edward Jones-Lopez, an infectious disease expert at Keck Medicine of University of Southern California.

Here's what you need to know, Jones-Lopez said in a Keck news release.

After lab and animal testing, vaccines enter a phase 1 clinical trial, where a small group of people (10-50) gets the vaccine to see the right dose, side effects and safety. Phase 2 expands it to hundreds of people to test a vaccine for safety and effectiveness.

Phase 3 trials expand to tens of thousands of people to see if the vaccine protects against the infection or severe disease, and to continue to assess safety in a larger population. The U.S. Food and Drug Administration approves a vaccine only after a successful phase 3 trial.

In a phase 3 trial, people are randomly selected to receive the vaccine or a placebo. Researchers then compare how many in each group become infected.

The FDA says that a vaccine must be at least 50% effective in preventing COVID-19 or protecting against serious illness if someone does get infected.

One or more vaccines may become available three to six months after completion of a trial. That could be as soon as early next year.

Jones-Lopez said people may need to be vaccinated each year, just as for the flu, but we don't know yet.

How is the vaccine being developed so quickly? "We are benefiting from previous work done over the last decades to find safe, effective vaccines faster," Jones-Lopez said. Despite the speed of development, scientists are adhering to same safety standards followed for other approved vaccines, he said.

More information

The U.S. Centers for Disease Control and Prevention has more on the new coronavirus.

SOURCE: Keck Medicine of University of Southern California, news release, Oct. 22, 2020